Adragos Pharma inaugurates a new production line in France

Adragos Pharma (formerly Haupt Pharma) has reached a new milestone. At the beginning of November, the subsidiary based in Livron (Drôme) of the German pharmaceutical group presented its fourth production line dedicated to sterile injectable ampoules, the result of an investment of 13 million euros.

This new equipment, which increases production capacity by 40%, marks a turning point in the group's ambitions, also generating 40 local jobs. Andreas Raabe, CEO of Adragos, aims to place the company among the top 15 global pharmaceutical subcontractors by 2026. With this modern line, Adragos Pharma affirms its key role in the pharmaceutical industry and its commitment to innovation and growth.

https://www.ledauphine.com/sante/2024/11/12/avec-sa-nouvelle-ligne-de-production-adragos-pharma-change-de-braquet